These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18074360)

  • 1. Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide.
    Di Filippo M; Tambasco N; Muzi G; Balucani C; Saggese E; Parnetti L; Calabresi P; Rossi A
    Mov Disord; 2008 Feb; 23(3):468-70. PubMed ID: 18074360
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of injection of potassium cyanide into the sciatic nerve of the adult mouse: in vivo and electron microscopic studies.
    Hall SM
    J Neurocytol; 1972 Oct; 1(3):233-54. PubMed ID: 8530963
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyanide-induced changes in the levels of neurotransmitters in discrete brain regions of rats and their response to oral treatment with alpha-ketoglutarate.
    Hariharakrishnan J; Satpute RM; Bhattacharya R
    Indian J Exp Biol; 2010 Jul; 48(7):731-6. PubMed ID: 20929056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicokinetic profiles of α-ketoglutarate cyanohydrin, a cyanide detoxification product, following exposure to potassium cyanide.
    Mitchell BL; Bhandari RK; Bebarta VS; Rockwood GA; Boss GR; Logue BA
    Toxicol Lett; 2013 Sep; 222(1):83-9. PubMed ID: 23867915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversible Parkinsonism and cognitive impairment following treatment with valproate].
    Toribio-Díaz ME; Morera-Guitart J; Palao-Duarte S
    Rev Neurol; 2008 Oct 1-15; 47(7):390-1. PubMed ID: 18841554
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of long-term low-dose cyanide administration to rats.
    Soto-Blanco B; Marioka PC; Górniak SL
    Ecotoxicol Environ Saf; 2002 Sep; 53(1):37-41. PubMed ID: 12481854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of prolonged administration of cyanide, thiocyanate and chokecherry (Prunus virginiana) to goats.
    Soto-Blanco B; Stegelmeier BL; Pfister JA; Gardner DR; Panter KE
    J Appl Toxicol; 2008 Apr; 28(3):356-63. PubMed ID: 17631662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons.
    Merchant RA; Li B; Yap KB; Ng TP
    Age Ageing; 2009 Jan; 38(1):105-8. PubMed ID: 19008305
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders.
    Cox LA
    Neurology; 2006 Feb; 66(4):616-7; author reply 616-7. PubMed ID: 16505338
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mental confusion during the treatment of Parkinson disease with trihexyphenidyl].
    Graux P; Durocher AM; Copin JM
    Lille Med; 1980; 25(6):271-2. PubMed ID: 7401896
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sleep disorders and cognitive impairment: the cause and reaction].
    Porat Katz BS
    Harefuah; 2009 May; 148(5):320-1, 349. PubMed ID: 19630363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance.
    Milewski I
    Neurology; 2008 Apr; 70(14):1221; author reply 1221-2. PubMed ID: 18378888
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism].
    Ruiz-Rizzo AL; Tirado V; Moreno-Carrillo C; Aguirre-Acevedo DC; Murillo O; Lopera F
    Rev Neurol; 2009 Aug 1-15; 49(3):123-30. PubMed ID: 19621306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [For and against potassium cyanide in "Doctor Glas"].
    Sjöstrand NO
    Lakartidningen; 2003 Nov; 100(46):3792. PubMed ID: 14655343
    [No Abstract]   [Full Text] [Related]  

  • 17. Nondemented Parkinson disease patients: is cognitive performance associated with depressive difficulties?
    Klepac N; Trkulja V; Relja M
    Cogn Behav Neurol; 2008 Jun; 21(2):87-91. PubMed ID: 18541984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does laterality of motor impairment tell us something about cognition in Parkinson disease?
    Cooper CA; Mikos AE; Wood MF; Kirsch-Darrow L; Jacobson CE; Okun MS; Rodriguez RL; Bowers D; Fernandez HH
    Parkinsonism Relat Disord; 2009 May; 15(4):315-7. PubMed ID: 18793864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupation and risk of parkinsonism: a multicenter case-control study.
    Tanner CM; Ross GW; Jewell SA; Hauser RA; Jankovic J; Factor SA; Bressman S; Deligtisch A; Marras C; Lyons KE; Bhudhikanok GS; Roucoux DF; Meng C; Abbott RD; Langston JW
    Arch Neurol; 2009 Sep; 66(9):1106-13. PubMed ID: 19752299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.